GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Arich Enterprise Co 4173.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

18.10

+1.40%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Arich Enterprise Co

Its shares trade on Taipei Exchange under the ticker 4173.TWO. It has been listed since 10 July 2012. In the fiscal year to 31 December 2025, it reported revenue of TWD 1.55bn and net income of TWD 86.8m. At that date it held total assets of TWD 5.26bn and shareholders' equity of TWD 2.01bn.

Arich Enterprise Co., Ltd. engages in the provision of medical sales, promotion, and logistics services. The company is headquartered in Taipei, New Taipei. The company went IPO on 2012-07-10. The firm is principally engaged in the sale and marketing of prescription drugs for gynaecology, obstetrics, urinary, derma and ophthalmology use; guideline drugs for hair breeding, intestines and stomach and smoking quit, as well as health consumer goods for oral health, daily consuming and beauty care, among others. The firm also provides distribution and logistics services for prescription drugs, guideline drugs, restriction drugs, cold chain drugs, clinical trial drugs and healthcare products, among others. The firm operates its business mainly within domestic market.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Providers & Services
Listed since
10 Jul 2012
Employees
233

Leadership

Pay as last reported

  • Mr. Ming-Cheng ChangChairman of the Board
  • Yiyan LuChief Financial Officer
  • Shiwei BiaoGeneral Manager, since 2023
  • Ms. Wen-Hwa ChangDeputy General Manager
  • Yiwen LinCorporate Governance Officer
  • Ruoxuan FuDirector
  • Wenlin SuDirector
  • Fuquan XueDirector
  • Mr. Xianzheng ZhangDirector, since 2011
  • Chenxiao ZhouDirector
  • Detai DongIndependent Director
  • Changsheng WangIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Headquartered in Taipei, New Taipei
  • Provides medical sales, promotion, and logistics services
  • Operates primarily within the domestic market

Weaknesses

  • No specific weaknesses mentioned in the provided information
  • Limited international market presence
  • No details on financial performance or market share

Opportunities

  • Expansion into international markets for medical services
  • Growth in prescription drug sales for specific medical fields
  • Potential for increased distribution of healthcare products

Threats

  • Dependence on domestic market for business operations
  • Competition in the healthcare sector
  • Regulatory challenges in the healthcare industry

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.